News

Under this amendment, the companies have jointly agreed to expand the investment in the ongoing clinical development plan for Erbitux by up to several hundred million dollars. Development

Biogen Idec and Elan have submitted studies to support their bid for approval. However, documents on the FDA website reveal that they did not show Tysabri to be

Conducted by a team of researchers in Denmark, the study focused on ovariectomized rats, a model that closely resembles the changes in the human skeletal system during menopause.

Around 26,000 people develop wet AMD in the UK each year, and the disease can cause impaired vision, leading to blindness. The National Institute for Health and Clinical

In a clinical study, Vyvanse provided consistent ADHD symptom control throughout the day based upon parent reports in the morning (approximately 10am), afternoon (approximately 2pm), and early evening

The Commercial Court of First Instance Number 4 in Barcelona, which issued the ruling, found a second patent covering a stabilized formulation that includes atorvastatin is invalid. The

The entire transaction is valued at about $790 million, comprised of the 24.4 million company shares that were outstanding as of April 28 as well as $30.50 each

Eliezer Zomer, executive vice president, product development & manufacturing, Pro-Pharmaceuticals, explained: “Biliary tract and gall bladder cancers are challenging to treat, especially after failure of surgery which is

Previous research has indicated that abnormal levles of lipids are associated with HIV patients on antiretroviral treatment. Abnormal lipid levels could lead to an increased risk of adverse